Ten kinds of medicines were found to be unqualified, including manufacturers such as Wuhan Jianmin

The impact of drug substandards on consumers is not negligible. Today's Beijing Food and Drug Administration announced the latest results of drug testing in the fourth quarter of 2011. A total of 10 varieties were found to be unqualified in various degrees, including several large ones. Factory products. It is chilling, how much security is there around us, how can we make a healthy life, and it has become our most concerned issue. Fortunately, we have not found the above-mentioned substandard products sold in major pharmacies. The City Food and Drug Administration reminds consumers that once they are found, please call to report.

Disqualification of the discriminator is worthy

Yesterday, many domestic websites reported on the results of drug sampling conducted by the Beijing Food and Drug Administration in the fourth quarter of last year. A total of ten batches of unqualified products were sampled. There were no injections, mostly capsules, tablets, or pieces of Chinese medicine. For inspection, character, identification and other items failed. Among them are the products of major manufacturers such as Shanghai Lei Yunshang, Tonghua Shenghe, Harbin Pharmaceutical Group, and Wuhan Jianmin.

“Unqualified items such as inspections and traits are common problems that do not have any adverse effects on drug safety and drug efficacy. For example, the specific moisture content of certain drugs may affect the product because of differences in geographical location between the north and the south. The characteristics of this, and fake drugs, counterfeit drugs, there are essential differences." Industry experts said that the identification of non-conformities deserve attention, once it is this issue, usually represents two possibilities: First, the legitimate products of the regular manufacturers were The second is that the pharmaceutical ingredients produced by regular manufacturers are unqualified, which is rarely seen in general.

Norfloxacin capsules, Tianma capsules, and powerful Tianma Eucommia capsules are widely used in the market as broad-spectrum antibacterial drugs and cardiovascular disease-assisting drugs. Once the problem is spotted, the expert has emphasized that the “identification item is not qualified”. Especially worth noting.

No unfair product has been found in our city

Yesterday, we visited a number of pharmacies and pharmacies such as the main city Peace Pharmacy, Tongjunge Pharmacy, and Xinyi Pharmacy. We did not find the above-mentioned batches of unqualified products.

According to the person in charge of the Shanghai Food and Drug Administration, the provincial food and drug regulatory authorities will regularly sample and publish the quality of the drug in the market. If problems are found, the food and drug administration department of the place of production will be instructed to check and ask the manufacturer to recall. The city drug administration department also indicated that it would dynamically monitor the sampling product and urge the pharmacies to self-inspect.

The State Food and Drug Administration has asked the provinces (autonomous regions and municipalities) of the Food and Drug Administration to strengthen the supervision and inspection within the jurisdiction. At the same time to remind consumers, once found, please call the 68810509 telephone report.